Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 13/20 | 0.49 |
| ▸ | CNR1 | P21554 | 5/20 | 0.49 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.42 |
| ▸ | RORC | P51449 | 1/20 | 0.35 |
| ▸ | SMO | Q99835 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1463796 | 0.88 | CNR2 (0.52) | CNR2CNR1HSD11B1RORCSMO | |
| SCHEMBL1465137 | 0.85 | CNR2 (0.58) | CNR2CNR1RORCPOLB | |
| SCHEMBL3967901 | 0.84 | FFAR2 (0.49) | CNR2CNR1HSD11B1 | |
| SCHEMBL1465040 | 0.81 | HSD11B1 (0.55) | CNR2CNR1HSD11B1SMO | |
| SCHEMBL1465768 | 0.79 | CNR2 (0.59) | CNR2CNR1RORCPOLB | |
| SCHEMBL3963986 | 0.78 | CNR2 (0.43) | CNR2CNR1HSD11B1 | |
| SCHEMBL3963850 | 0.77 | RORC (0.41) | CNR2CNR1HSD11B1RORC | |
| SCHEMBL1465201 | 0.75 | CNR2 (0.60) | CNR2CNR1POLB | |
| SCHEMBL1463777 | 0.75 | CNR2 (0.58) | CNR2CNR1RORC | |
| SCHEMBL1464341 | 0.74 | ALDH1A1 (0.58) | CNR2CNR1RORCPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2081905-A2 | SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR | Boehringer Ingelheim International GmbH (DE) | 2009-07-29 | — | — | EP | disclosed |
| WO-2008014199-A2 | SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-01-31 | — | — | WO | disclosed |